Bionano Genomics

BNGONasdaq United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$20.021 M

$1.70 -6.59%

Close of 23 Sept 2026

Revenue

$28.5M

#2890 by revenue

Earnings

-$26.4M

Loss-making

Shares outstanding

11,777,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →

#18PrecipioPRPO$42.7M
#19Circle8 GroupCIRC$38.9M
#20Harvard BioscienceHBIO$36.6M
#21Bionano GenomicsBNGO$20.0M
#22AstrotechASTC$15.6M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Bionano Genomics, worth $4.86K. Grants and option exercises are excluded.

Albert LudererInterim Chief Executive$4.86K
4,000 shares at $1.22 on 21 Aug 2026 · filed 21 Aug 2026

What if Bionano Genomics were worth as much as…

Open the what-if tool →

Gold $29.8T

$2,534,340

Per share 1,490,788× higher

Bitcoin $1.69T

$143,849.91

Per share 84,618× higher

Nvidia $5.43T

$461,474.99

Per share 271,456× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Bionano Genomics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.